SE420565B - Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel - Google Patents

Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel

Info

Publication number
SE420565B
SE420565B SE7407462A SE7407462A SE420565B SE 420565 B SE420565 B SE 420565B SE 7407462 A SE7407462 A SE 7407462A SE 7407462 A SE7407462 A SE 7407462A SE 420565 B SE420565 B SE 420565B
Authority
SE
Sweden
Prior art keywords
intravascular administration
aid
suspension
solution
connection
Prior art date
Application number
SE7407462A
Other languages
English (en)
Swedish (sv)
Other versions
SE7407462L (sv
Inventor
U S E Rothman
B J Lindberg
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE7407462A priority Critical patent/SE420565B/xx
Priority to AU81647/75A priority patent/AU8164775A/en
Priority to DE19752524279 priority patent/DE2524279A1/de
Priority to US05/583,217 priority patent/US4124705A/en
Priority to GB24288/75A priority patent/GB1518121A/en
Priority to CA228,793A priority patent/CA1037950A/en
Priority to FR7517633A priority patent/FR2273555A1/fr
Priority to JP50067730A priority patent/JPS6125689B2/ja
Priority to NL7506757A priority patent/NL7506757A/xx
Publication of SE7407462L publication Critical patent/SE7407462L/
Publication of SE420565B publication Critical patent/SE420565B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C08B31/006—Crosslinking of derivatives of starch

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7407462A 1974-06-06 1974-06-06 Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel SE420565B (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE7407462A SE420565B (sv) 1974-06-06 1974-06-06 Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel
AU81647/75A AU8164775A (en) 1974-06-06 1975-05-29 An agent for intravascular administration
DE19752524279 DE2524279A1 (de) 1974-06-06 1975-05-31 Mittel zur intravaskulaeren verabreichung und verfahren zu seiner herstellung
US05/583,217 US4124705A (en) 1974-06-06 1975-06-02 Agent for intravascular administration
GB24288/75A GB1518121A (en) 1974-06-06 1975-06-05 Agent for intravascular administration
CA228,793A CA1037950A (en) 1974-06-06 1975-06-05 Agent for intravascular administration
FR7517633A FR2273555A1 (fr) 1974-06-06 1975-06-05 Agent d'administration intravasculaire
JP50067730A JPS6125689B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-06-06 1975-06-06
NL7506757A NL7506757A (nl) 1974-06-06 1975-06-06 Middel voor intravasculaire toediening.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7407462A SE420565B (sv) 1974-06-06 1974-06-06 Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel

Publications (2)

Publication Number Publication Date
SE7407462L SE7407462L (sv) 1975-12-08
SE420565B true SE420565B (sv) 1981-10-19

Family

ID=20321349

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7407462A SE420565B (sv) 1974-06-06 1974-06-06 Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel

Country Status (9)

Country Link
US (1) US4124705A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS6125689B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU8164775A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1037950A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2524279A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2273555A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1518121A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7506757A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE420565B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002772A1 (en) * 1983-12-21 1985-07-04 Schroeder Ulf Diagnostic and contrast agent

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5283960A (en) * 1976-01-01 1977-07-13 Pharmacia Ab Medicine for administrating in blood
DE2908437A1 (de) * 1979-03-05 1980-09-18 Fresenius Chem Pharm Ind Vernetzte hydroxyaethylstaerke
US4276885A (en) * 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4385046A (en) * 1980-12-15 1983-05-24 Minnesota Mining And Manufacturing Company Diagnostic radio-labeled polysaccharide derivatives
US4431626A (en) * 1981-05-27 1984-02-14 The Regents Of The University Of California Tc-99m Labeled carrier for imaging
FR2548902B1 (fr) * 1983-07-13 1986-04-11 Guerbet Sa Gel pour embolisation therapeutique
US5266333A (en) * 1985-03-06 1993-11-30 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
US4680171A (en) * 1985-03-15 1987-07-14 William Shell Visualization of a bloodstream circulation with biodegradable microspheres
JPS62236839A (ja) * 1986-04-08 1987-10-16 Yoshiaki Motozato 架橋されたグルコマンナン球状粒子及びその製法
GB8801646D0 (en) * 1988-01-26 1988-02-24 Nycomed As Chemical compounds
US5948387A (en) * 1990-06-01 1999-09-07 Imarx Pharmaceutical Corp. Contrast media for ultrasonic imaging
US5420176A (en) * 1990-06-01 1995-05-30 Imarx Pharmaceutical Corp. Contrast media for ultrasonic imaging
ATE130517T1 (de) * 1990-08-08 1995-12-15 Takeda Chemical Industries Ltd Intravaskulär embolisierendes mittel mit gehalt an einem die angiogenesis hemmenden stoff.
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
US5233995A (en) * 1991-11-21 1993-08-10 Sterling Winthrop Inc. Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods
NZ254048A (en) * 1992-07-24 1995-09-26 Labopharm Inc Solid controlled release pharmaceutical composition comprising cross linked amylose
US5514379A (en) * 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
DE69635127T2 (de) * 1995-06-06 2006-06-29 C.R. Bard, Inc. Verfahren zur herstellung von vernetzten wasserlöslichen polymerpartikel, die partikel und ihre verwendung
US6214331B1 (en) 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7871637B2 (en) 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US6066325A (en) * 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US6261320B1 (en) 1996-11-21 2001-07-17 Radiance Medical Systems, Inc. Radioactive vascular liner
US5782742A (en) * 1997-01-31 1998-07-21 Cardiovascular Dynamics, Inc. Radiation delivery balloon
US6458069B1 (en) 1998-02-19 2002-10-01 Endology, Inc. Multi layer radiation delivery balloon
US6491619B1 (en) 1997-01-31 2002-12-10 Endologix, Inc Radiation delivery catheters and dosimetry methods
US5993374A (en) * 1997-06-17 1999-11-30 Radiance Medical Systems, Inc. Microcapsules for site-specific delivery
US6048299A (en) * 1997-11-07 2000-04-11 Radiance Medical Systems, Inc. Radiation delivery catheter
US6149574A (en) * 1997-12-19 2000-11-21 Radiance Medical Systems, Inc. Dual catheter radiation delivery system
JP2002503533A (ja) 1998-02-19 2002-02-05 ラディアンス・メディカル・システムズ・インコーポレイテッド 放射性ステント
US6203778B1 (en) * 1998-12-08 2001-03-20 The Regents Of The University Of California Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization
EP1255547B1 (en) 2000-02-08 2008-08-20 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
US8834864B2 (en) 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
ATE503465T1 (de) 2004-10-25 2011-04-15 Celonova Biosciences Germany Gmbh Beladbare polyphosphazenhaltige teilchen für therapeutische und/oder diagnostische anwendungen sowie herstellungs- und verwendungsverfahren dafür
CA2651941C (en) 2006-05-31 2015-02-17 Baxter International Inc. Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
US8623842B2 (en) 2006-09-27 2014-01-07 Hemostasis, Llc Hemostatic agent and method
US8790698B2 (en) 2007-10-30 2014-07-29 Baxter International Inc. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
RU2545810C2 (ru) 2008-02-29 2015-04-10 Ферросан Медикал Дивайсиз А/С Устройство для ускорения остановки кровотечения и/или заживления ран
US9061087B2 (en) * 2008-03-04 2015-06-23 Hemostasis, Llc Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
US9162006B2 (en) 2009-06-16 2015-10-20 Baxter International Inc. Hemostatic sponge
JP2013502263A (ja) 2009-08-18 2013-01-24 ベン‐グリオン ユニバーシティ オブ ザ ネゲヴ リサーチ アンド デベロップメント オーソリティ 撮像データを解析するためのシステムおよび方法
MX2012007056A (es) 2009-12-16 2012-09-28 Baxter Healthcare Sa Esponja hemostatica.
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
MX352875B (es) 2010-06-01 2017-12-13 Baxter Healthcare Sa Proceso para elaborar composiciones hemostaticas secas y estables.
BR112012030463B1 (pt) 2010-06-01 2021-08-24 Baxter International Inc. Processo para fabricar uma composição hemostática seca e estável, recipiente acabado final, kit para administrar uma composição hemostática, e, grânulos revestidos com trombina
EP2575775B1 (en) 2010-06-01 2018-04-04 Baxter International Inc. Process for making dry and stable hemostatic compositions
US9381269B2 (en) 2011-04-13 2016-07-05 Avent, Inc. Biosorbable wound treatment device, process for making, and method of using the same
CN103957949B (zh) 2011-10-11 2017-07-18 巴克斯特国际公司 止血组合物
JP6195568B2 (ja) 2011-10-11 2017-09-13 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 止血組成物
AU2012330450B2 (en) 2011-10-27 2017-04-27 Baxter Healthcare Sa Hemostatic compositions
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
CN104349797B (zh) 2012-06-12 2017-10-27 弗罗桑医疗设备公司 干止血组合物
WO2014202760A2 (en) 2013-06-21 2014-12-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
CA2928963C (en) 2013-12-11 2020-10-27 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
WO2016058612A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
BR112017013565B1 (pt) 2014-12-24 2021-12-28 Ferrosan Medical Devices A/S Seringa para retenção e mistura de primeira e segunda substâncias
RU2717356C2 (ru) 2015-07-03 2020-03-23 Ферросан Медикал Дивайсиз А/С Шприц для удерживания вакуума в состоянии хранения
JP6523510B1 (ja) 2018-03-30 2019-06-05 Ｊｘ金属株式会社 スパッタリングターゲット
ES2968412T3 (es) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Método para preparar una composición hemostática

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2626257A (en) * 1952-05-21 1953-01-20 Johnson & Johnson Medical dusting powder
NL126243C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1959-06-12
SE372421B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1968-04-01 1974-12-23 Minnesota Mining & Mfg
JPS5439444B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1971-08-21 1979-11-28

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002772A1 (en) * 1983-12-21 1985-07-04 Schroeder Ulf Diagnostic and contrast agent

Also Published As

Publication number Publication date
CA1037950A (en) 1978-09-05
US4124705A (en) 1978-11-07
JPS6125689B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-06-17
AU8164775A (en) 1976-12-02
DE2524279A1 (de) 1975-12-18
FR2273555B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-10-06
NL7506757A (nl) 1975-12-09
JPS517115A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-01-21
DE2524279C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-07-12
SE7407462L (sv) 1975-12-08
GB1518121A (en) 1978-07-19
FR2273555A1 (fr) 1976-01-02

Similar Documents

Publication Publication Date Title
SE420565B (sv) Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel
SE7501328L (sv) Sammansatt elektrod for anvendning vid respirator och/eller hjertovervaknings av spedbarn.
IL46919A (en) 16-hydroxy-16-alkyl prostanoic acid derivatives and their preparation
NO154797C (no) Analogifremgangsmaate for fremstilling av cefalosporinforbindelser i den syn-isomere form eller ugiftige salter derav
DK407675A (da) Sugekateter
SE409856B (sv) Cyklopropankarboxylsyraestrar med insekticid och akaricid verkan
AT354604B (de) Blutfiltereinheit
SE440595B (sv) Forfaraande for framstellning av mjuka dinatriumkromoglykatpelletkulor for inhalering
SE393138B (sv) Forfarande for blekning av cellulosa med en syre innehallande gas i nervaro av natriumbikarbonat
SE7510755L (sv) Kateteradapter
GB1445964A (en) Diagnostic agent for the detection of glucose in urine
SE423315B (sv) Andningskateter
SE383046B (sv) Anordning for indikering av ett foremals legesforendringar
SE401182B (sv) Furanhydroxamsyraderivat med fungicid verkan
ZA75179B (en) New arylpiperazine derivatives of adenine and the preparation thereof
SE431204B (sv) Forfarande for framstellning av n?722-naftalensulfonyl-l-argininestrar och -amider eller farmaceutiskt accepterbara syraadditionssalter derav
IT1036193B (it) Respiratore pediatrico
SE423236B (sv) Forfarande for framstellning av natriumsalter av amoxicillin
SE413280B (sv) Saett vid tillverkning av ett aetbart korvskinn av kollagen
SE7509897L (sv) Basiskt substituerade 3-sulfamoylbensoesyraderivat och forfarande for deras framstellning
FR2295042A1 (fr) Agents ignifugeants phosphores utilisables dans la preparation de polyurethannes
SE433217B (sv) Forfarande for framstellning av 6 aminopenicillansyra eller 7 aminocefalosporansyraderivat
SE431547B (sv) Forfarande for framstellning av 3-metylencefamsulfoxider
IT962116B (it) Derivati dell acido 2 cloroetan fosfonico
IT1031883B (it) Preparazione di polioli

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7407462-6

Effective date: 19940710

Format of ref document f/p: F